Sort   by:  
 Page size 
TranscriptomicsNla18/DK1622
NtrC-like activators regulate transcription of a wide variety of adaptive genes in bacteria. Previously we demonstrated that a mutation in the NtrC-like activator gene nla18 severely inhibits M. xanthus fruiting body development and vegetative growth. In this study, we found that inactivation of n...
ORGANISM(S): Myxococcus xanthus 
2010-06-30 | E-GEOD-3323 | biostudies-arrayexpress
TranscriptomicsVP963/DK1622
Phosphate regulation is complex in the developmental prokaryote Myxococcus xanthus, and requires at least three previously characterized two-component systems (TCS), designated PhoR1-PhoP1, PhoR2-PhoP2, and PhoR3-PhoP3. We report here the identification and characterization of a member of a fourth ...
ORGANISM(S): Myxococcus xanthus 
2010-06-30 | E-GEOD-3795 | biostudies-arrayexpress
UnknownSoil protist function varies with elevation in the Swiss Alps.
Not available
S-EPMC9290697 | biostudies-literature
UnknownShotgun metagenome data of a defined mock community using Oxford Nanopore, PacBio and Illumina technologies.
Not available
S-EPMC6879543 | biostudies-literature
UnknownDiscriminating α-synuclein strains in Parkinson's disease and multiple system atrophy.
Not available
S-EPMC7066875 | biostudies-literature
UnknownEconomic Impact of Severe Early-Onset Foetal Growth Restriction: A Multicentre Prospective Cohort Study.
Not available
S-EPMC12676201 | biostudies-literature
UnknownEffect of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey.
Not available
S-EPMC7446625 | biostudies-literature
ProteomicsIdentifying proteins altered during Methyl methanesulfonate treatment
Humans are exposed to a wide range of exogenous and endogenous alkylating agents, including agents frequently used as cytostatic drugs in cancer treatment (Drablos, Feyzi et al. 2004). Alkylating agents are mutagenic and cytotoxic and the major body of research has focused on their effects upon DNA....
ORGANISM(S): Homo sapiens (Human) 
2021-08-30 | PXD003549 | Pride
Proteomics Methyl methanesulfonate Prbitrap Silac Label-free Dna damage Quantification 
UnknownTarget engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial.
Not available
S-EPMC11405261 | biostudies-literature
UnknownGreater topoclimatic control of above- versus below-ground communities.
Not available
S-EPMC7756268 | biostudies-literature
Sort   by:  
 Page size